I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Zhenggang Ren
294
results:
Search for persons
X
Format
Online (294)
Mediatypes
Articles (Online) (154)
Bookchapter (Online) (2)
OpenAccess-fulltext (138)
Languages
english (276)
Sorted by: Relevance
Sorted by: Year
?
1
Identification of a Macrophage marker gene signature to eva..:
Li, Tong
;
Xu, Xin
;
Guo, Mengzhou
...
Heliyon. 10 (2024) 11 - p. e31881 , 2024
Link:
https://doi.org/10.1016/..
?
2
Proteomic and metabolomic features in patients with HCC res..:
Li, Zhong-Chen
;
Wang, Jie
;
Liu, He-Bin
...
Cell Reports. 43 (2024) 3 - p. 113877 , 2024
Link:
https://doi.org/10.1016/..
?
3
A Phase 3 Study of Pembrolizumab versus Placebo for Previou..:
Qin, Shukui
;
Fang, Weijia
;
Ren, Zhenggang
...
Liver Cancer. , 2024
Link:
https://doi.org/10.1159/..
?
4
Real-world study of hepatic artery infusion chemotherapy co..:
Li, Jinghuan
;
Quan, Bing
;
Liu, Wenfeng
...
Therapeutic Advances in Medical Oncology. 16 (2024) - p. , 2024
Link:
https://doi.org/10.1177/..
?
5
Development and Validation of a Nomogram for Patients Under..:
Xie, Diyang
;
Li, Zhongchen
;
Yuan, Jia
...
Journal of Hepatocellular Carcinoma. 11 (2024) - p. 693-705 , 2024
Link:
https://doi.org/10.2147/..
?
6
A synergistic regulation works in matrix stiffness-driven i..:
Zhang, Xi
;
Zhao, Yingying
;
Li, Miao
...
Cancer Letters. 582 (2024) - p. 216597 , 2024
Link:
https://doi.org/10.1016/..
?
7
Analysis of transient laminar forced convective heat transf..:
Liu, Jianqiang
;
Ruan, Xiaodong
;
Hu, Liang
...
International Journal of Heat and Mass Transfer. 216 (2023) - p. 124585 , 2023
Link:
https://doi.org/10.1016/..
?
8
Lenvatinib plus pembrolizumab versus lenvatinib plus placeb..:
Llovet, Josep M
;
Kudo, Masatoshi
;
Merle, Philippe
...
The Lancet Oncology. 24 (2023) 12 - p. 1399-1410 , 2023
Link:
https://doi.org/10.1016/..
?
9
Oxaliplatin-Resistant Hepatocellular Carcinoma Drives Immun..:
Zhang, Feng
;
Hu, Keshu
;
Liu, Wenfeng
...
Cellular and Molecular Gastroenterology and Hepatology. 15 (2023) 3 - p. 573-591 , 2023
Link:
https://doi.org/10.1016/..
?
10
Pembrolizumab in combination with gemcitabine and cisplatin..:
Kelley, Robin Kate
;
Ueno, Makoto
;
Yoo, Changhoon
...
The Lancet. 401 (2023) 10391 - p. 1853-1865 , 2023
Link:
https://doi.org/10.1016/..
?
11
Guidelines for the Diagnosis and Treatment of Primary Liver..:
Zhou, Jian
;
Sun, Huichuan
;
Wang, Zheng
...
Liver Cancer. 12 (2023) 5 - p. 405-444 , 2023
Link:
https://doi.org/10.1159/..
?
12
Camrelizumab plus rivoceranib versus sorafenib as first-lin..:
Qin, Shukui
;
Chan, Stephen L
;
Gu, Shanzhi
...
The Lancet. 402 (2023) 10408 - p. 1133-1146 , 2023
Link:
https://doi.org/10.1016/..
?
13
Toripalimab combined with lenvatinib and GEMOX is a promisi..:
Shi, Guo-Ming
;
Huang, Xiao-Yong
;
Wu, Dong
...
Signal Transduction and Targeted Therapy. 8 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
14
Hepatocellular Carcinoma Patients with Hepatitis B Virus In..:
Du, Qi
;
Yuan, Jia
;
Ren, Zhenggang
Liver Cancer. , 2023
Link:
https://doi.org/10.1159/..
?
15
NLRP3/IL‐1β induced myeloid‐derived suppressor cells recrui..:
Liu, Wenfeng
;
Zhang, Feng
;
Quan, Bing
...
MedComm. 4 (2023) 6 - p. , 2023
Link:
https://doi.org/10.1002/..
1-15